United States securities and exchange commission logo





                          March 13, 2024

       Ofer Haviv
       Chief Executive Officer
       Evogene Ltd.
       13 Gad Feinstein Street, Park Rehovot, Rehovot
       7638517, Israel

                                                        Re: Evogene Ltd.
                                                            Registration
Statement on Form F-3
                                                            Filed March 1, 2024
                                                            File No. 333-277565

       Dear Ofer Haviv:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Juan
Grana at 202-551-6034 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Industrial Applications and

                          Services
       cc:                                              Mike Rimon, Esq.